Dr. Harvey Finkelstein is a Pain Management Specialist who has been practicing medicine for more than three decades. After receiving his medical degree from the Sackler School of Medicine in 1981, he completed five years of residency at Long Island Jewish Hospital and University Hospital at Stony Brook as well as two Fellowships (Pediatric and Cardiac Anesthesia; and Pain Management). In his final year of training at Stony Brook, he was the Chief Resident of the Anesthesia department. Dr. Finkelstein started his career as an assistant professor of Anesthesia at the University Hospital at Stony Brook. During that time he was a member of the Pediatric Anesthesia team and the Pain Management division. Hethen joined the Anesthesia Department at Central General Hospital in Plainview, New York.He was appointed the Director of Anesthesia at Central General Hospital and Plainview Hospital in Plainview, New York, serving from 1992 to 2000. During that time he helped establish the Pain Management service at Plainview Hospital and then in 2000 he devoted himself to the full time practice of pain management. Dr. Harvey Finkelstein has had the rare distinction of being an examiner for the World Institute of Pain’s Fellowship examination (FIPP) since 2011, an institution by which he was invited to Maastricht, Budapest, and Miami to participate in the administration of the exam – a rigorous 3-part examination testing oral, written and practical aspects, judging the examinee on knowledge and performance of 4 nerve blocks. This examination sets out to establish expertise in the specialty of Interventional Pain Medicine. Dr. Harvey Finkelstein is a member of the World Institute of Pain and the Spinal Interventional Society, for which he served on the Standards Committee for one year. In addition, he is a member of the New York State Pain Society. Since 2014, Dr. Harvey Finkelstein has focused on consulting with and teaching young physicians in the field of pain management how to optimize their interventional nerve block techniques for the purpose of improving safety and results. In addition, he has advised and developed programs to promote safe opioid prescribing practices.